Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
63.24 USD | -0.46% | +0.03% | -14.52% |
Apr. 17 | Exact Sciences Corporation announced that it has received $266.75 million in funding | CI |
Apr. 15 | Sector Update: Health Care Stocks Advance Premarket Monday | MT |
Financials (USD)
Sales 2024 * | 2.83B | Sales 2025 * | 3.23B | Capitalization | 11.53B |
---|---|---|---|---|---|
Net income 2024 * | -161M | Net income 2025 * | 6M | EV / Sales 2024 * | 4.6 x |
Net Debt 2024 * | 1.5B | Net Debt 2025 * | 1.08B | EV / Sales 2025 * | 3.91 x |
P/E ratio 2024 * |
-72
x | P/E ratio 2025 * |
2,425
x | Employees | 6,550 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.99% |
Latest transcript on Exact Sciences Corporation
1 day | -0.46% | ||
1 week | -0.97% | ||
Current month | -8.43% | ||
1 month | +1.84% | ||
3 months | -3.69% | ||
6 months | -1.25% | ||
Current year | -14.52% |
Managers | Title | Age | Since |
---|---|---|---|
Kevin Conroy
CEO | Chief Executive Officer | 58 | 09-03-17 |
Paul Limburg
CTO | Chief Tech/Sci/R&D Officer | - | 18-03-05 |
Jorge Garces
CTO | Chief Tech/Sci/R&D Officer | 52 | 21-01-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
D. Coward
BRD | Director/Board Member | 59 | 14-12-31 |
Kevin Conroy
CEO | Chief Executive Officer | 58 | 09-03-17 |
Freda Lewis-Hall
BRD | Director/Board Member | 69 | 20-04-21 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
6.80% | 1 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-24 | 63.24 | -0.46% | 1,213,599 |
24-04-23 | 63.53 | +1.79% | 1,777,688 |
24-04-22 | 62.41 | +2.38% | 1,594,417 |
24-04-19 | 60.96 | -3.97% | 2,168,842 |
24-04-18 | 63.48 | +0.41% | 1,597,962 |
Delayed Quote Nasdaq, April 24, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.52% | 11.53B | |
+44.03% | 3.31B | |
-33.09% | 2.11B | |
-18.60% | 2.05B | |
-27.59% | 1.49B | |
+17.10% | 1.02B | |
-3.06% | 741M | |
-33.50% | 426M | |
-46.94% | 374M | |
+27.44% | 372M |
- Stock Market
- Equities
- EXAS Stock